Literature DB >> 22593050

Egr-1 induces DARPP-32 expression in striatal medium spiny neurons via a conserved intragenic element.

Serene Keilani1, Samira Chandwani, Georgia Dolios, Alexey Bogush, Heike Beck, Antonis K Hatzopoulos, Gadiparthi N Rao, Elizabeth A Thomas, Rong Wang, Michelle E Ehrlich.   

Abstract

DARPP-32 (dopamine and adenosine 3', 5'-cyclic monophosphate cAMP-regulated phosphoprotein, 32 kDa) is a striatal-enriched protein that mediates signaling by dopamine and other first messengers in the medium spiny neurons. The transcriptional mechanisms that regulate striatal DARPP-32 expression remain enigmatic and are a subject of much interest in the efforts to induce a striatal phenotype in stem cells. We report the identification and characterization of a conserved region, also known as H10, in intron IV of the gene that codes for DARPP-32 (Ppp1r1b). This DNA sequence forms multiunit complexes with nuclear proteins from adult and embryonic striata of mice and rats. Purification of proteins from these complexes identified early growth response-1 (Egr-1). The interaction between Egr-1 and H10 was confirmed in vitro and in vivo by super-shift and chromatin immunoprecipitation assays, respectively. Importantly, brain-derived neurotrophic factor (BDNF), a known inducer of DARPP-32 and Egr-1 expression, enhanced Egr-1 binding to H10 in vitro. Moreover, overexpression of Egr-1 in primary striatal neurons induced the expression of DARPP-32, whereas a dominant-negative Egr-1 blocked DARPP-32 induction by BDNF. Together, this study identifies Egr-1 as a transcriptional activator of the Ppp1r1b gene and provides insight into the molecular mechanisms that regulate medium spiny neuron maturation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22593050      PMCID: PMC3752065          DOI: 10.1523/JNEUROSCI.5448-11.2012

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  69 in total

1.  In vivo cell-autonomous transcriptional abnormalities revealed in mice expressing mutant huntingtin in striatal but not cortical neurons.

Authors:  Elizabeth A Thomas; Giovanni Coppola; Bin Tang; Alexandre Kuhn; SoongHo Kim; Daniel H Geschwind; Timothy B Brown; Ruth Luthi-Carter; Michelle E Ehrlich
Journal:  Hum Mol Genet       Date:  2010-12-20       Impact factor: 6.150

2.  Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum.

Authors:  Paola Arlotta; Bradley J Molyneaux; Denis Jabaudon; Yutaka Yoshida; Jeffrey D Macklis
Journal:  J Neurosci       Date:  2008-01-16       Impact factor: 6.167

3.  DARPP-32 genomic fragments drive Cre expression in postnatal striatum.

Authors:  Alexey I Bogush; Lois E McCarthy; Chai Tian; Vicki Olm; Tracy Gieringer; Sanja Ivkovic; Michelle E Ehrlich
Journal:  Genesis       Date:  2005-05       Impact factor: 2.487

4.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

Authors:  R Luthi-Carter; A Strand; N L Peters; S M Solano; Z R Hollingsworth; A S Menon; A S Frey; B S Spektor; E B Penney; G Schilling; C A Ross; D R Borchelt; S J Tapscott; A B Young; J H Cha; J M Olson
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

5.  Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro.

Authors:  S Ivkovic; M E Ehrlich
Journal:  J Neurosci       Date:  1999-07-01       Impact factor: 6.167

6.  Reciprocal regulation of expression of the human adenosine 5'-triphosphate binding cassette, sub-family A, transporter 2 (ABCA2) promoter by the early growth response-1 (EGR-1) and Sp-family transcription factors.

Authors:  Warren Davis; Zhijian J Chen; Kristina E Ile; Kenneth D Tew
Journal:  Nucleic Acids Res       Date:  2003-02-01       Impact factor: 16.971

7.  Egr-1 regulates expression of the glial scar component phosphacan in astrocytes after experimental stroke.

Authors:  Heike Beck; Matthias Semisch; Carsten Culmsee; Nikolaus Plesnila; Antonis K Hatzopoulos
Journal:  Am J Pathol       Date:  2008-06-13       Impact factor: 4.307

8.  Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease.

Authors:  Boris S Spektor; David W Miller; Zane R Hollingsworth; Yoshio A Kaneko; Steven M Solano; Jennifer M Johnson; John B Penney; Anne B Young; Ruth Luthi-Carter
Journal:  Brain Res Mol Brain Res       Date:  2002-06-15

9.  Direct generation of functional dopaminergic neurons from mouse and human fibroblasts.

Authors:  Massimiliano Caiazzo; Maria Teresa Dell'Anno; Elena Dvoretskova; Dejan Lazarevic; Stefano Taverna; Damiana Leo; Tatyana D Sotnikova; Andrea Menegon; Paola Roncaglia; Giorgia Colciago; Giovanni Russo; Piero Carninci; Gianni Pezzoli; Raul R Gainetdinov; Stefano Gustincich; Alexander Dityatev; Vania Broccoli
Journal:  Nature       Date:  2011-07-03       Impact factor: 49.962

10.  Transcription Mapping of Embryonic Rat Brain Reveals EGR-1 Induction in SOX2 Neural Progenitor Cells.

Authors:  Timothy Wells; Kirsty Rough; David A Carter
Journal:  Front Mol Neurosci       Date:  2011-05-17       Impact factor: 5.639

View more
  10 in total

Review 1.  Darpp-32 and t-Darpp protein products of PPP1R1B: Old dogs with new tricks.

Authors:  Arabo Avanes; Gal Lenz; Jamil Momand
Journal:  Biochem Pharmacol       Date:  2018-12-12       Impact factor: 5.858

2.  DARPP-32 distinguishes a subset of adult-born neurons in zebra finch HVC.

Authors:  Jake V Aronowitz; John R Kirn; Carolyn L Pytte; Gloster B Aaron
Journal:  J Comp Neurol       Date:  2021-11-15       Impact factor: 3.028

3.  Induction of DARPP-32 by brain-derived neurotrophic factor in striatal neurons in vitro is modified by histone deacetylase inhibitors and Nab2.

Authors:  Samira Chandwani; Serene Keilani; Maitane Ortiz-Virumbrales; Andrika Morant; Steve Bezdecny; Michelle E Ehrlich
Journal:  PLoS One       Date:  2013-10-21       Impact factor: 3.240

4.  Cellular Prion Protein (PrPc) and Hypoxia: True to Each Other in Good Times and in Bad, in Sickness, and in Health.

Authors:  Sanja Ramljak; Holger Herlyn; Inga Zerr
Journal:  Front Cell Neurosci       Date:  2016-12-19       Impact factor: 5.505

5.  Maturation, Behavioral Activation, and Connectivity of Adult-Born Medium Spiny Neurons in a Striatal Song Nucleus.

Authors:  Jennifer Kosubek-Langer; Lydia Schulze; Constance Scharff
Journal:  Front Neurosci       Date:  2017-06-07       Impact factor: 4.677

6.  The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.

Authors:  Martijn van Hagen; Diewertje G E Piebes; Wim C de Leeuw; Ilona M Vuist; Willeke M C van Roon-Mom; Perry D Moerland; Pernette J Verschure
Journal:  BMC Genomics       Date:  2017-05-12       Impact factor: 3.969

7.  Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) Protects Striatal Cells and Improves Motor Function in Huntington's Disease Models: Role of PAC1 Receptor.

Authors:  Irene Solés-Tarrés; Núria Cabezas-Llobet; Benjamin Lefranc; Jérôme Leprince; Jordi Alberch; David Vaudry; Xavier Xifró
Journal:  Front Pharmacol       Date:  2022-01-28       Impact factor: 5.810

8.  Behavioral and transcriptome alterations in male and female mice with postnatal deletion of TrkB in dorsal striatal medium spiny neurons.

Authors:  Ellen M Unterwald; Michelle E Page; Timothy B Brown; Jonathan S Miller; Marta Ruiz; Karen A Pescatore; Baoji Xu; Louis French Reichardt; Joel Beverley; Bin Tang; Heinz Steiner; Elizabeth A Thomas; Michelle E Ehrlich
Journal:  Mol Neurodegener       Date:  2013-12-26       Impact factor: 14.195

9.  Striatal neurodevelopment is dysregulated in purine metabolism deficiency and impacts DARPP-32, BDNF/TrkB expression and signaling: new insights on the molecular and cellular basis of Lesch-Nyhan Syndrome.

Authors:  Ghiabe-Henri Guibinga; Nikki Barron; William Pandori
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

10.  Nuclear Receptor Nr4a1 Regulates Striatal Striosome Development and Dopamine D1 Receptor Signaling.

Authors:  Maria-Daniela Cirnaru; Chiara Melis; Tomas Fanutza; Swati Naphade; Kizito-Tshitoko Tshilenge; Brian S Muntean; Kirill A Martemyanov; Joshua L Plotkin; Lisa M Ellerby; Michelle E Ehrlich
Journal:  eNeuro       Date:  2019-10-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.